SC
AXGN icon

SummitTX Capital’s Axogen AXGN Stock Holding History

SummitTX Capital’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.25M Sell
70,255
-164,240
-70% -$6.62M 0.08% 253
2026
Q1 		$7.77M Buy
+234,495
New +$7.62M 0.24% 96

Other funds holding AXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

SummitTX Capital's AXGN Position: Q2 2026 in Review

SummitTX Capital reduced its Axogen (AXGN) stake by 70% in Q2 2026, selling an estimated $6.62M and leaving 70,255 shares worth $3.25M. The position accounts for 0.08% of the portfolio, ranked #253.

SummitTX Capital first reported a position in AXGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.77M in Q1 2026. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • SummitTX Capital held 70,255 shares of Axogen worth $3.25M as of Q2 2026.
  • SummitTX Capital sold 164,240 Axogen shares in Q2 2026, an estimated $6.62M.
  • Axogen made up 0.08% of SummitTX Capital's portfolio in Q2 2026, its #253 holding.
  • SummitTX Capital first reported a position in Axogen in Q1 2026 and has held it in 2 quarters since.
  • SummitTX Capital's Axogen position peaked at $7.77M in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.